Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Measuring Social Toxicity in Acute Myeloid Leukemia

Erica E Fortune, Kimberly Rogers, Caroline Lawrence, Claire Saxton, Victoria G Morris, Thomas W LeBlanc, Maria Sae-Hau, Melissa F Miller

Blood (2023) 142 (Supplement 1): 5182.

https://doi.org/10.1182/blood-2023-177783

Published: 2023

Journal Articles

Communication That Enables Shared Decision-Making in Myelodysplastic Syndrome Is Suboptimal: Early Results from the Cancer Experience Registry

Melissa F Miller, Kimberly Rogers, Stuart L. Goldberg, Erica E Fortune, Victoria G Morris, Tracey Iraca, Claire Saxton

Blood (2023) 142 (Supplement 1): 2435.

https://doi.org/10.1182/blood-2023-189592

Published: 2023

Journal Articles

Financial Toxicity and Cost-Management Behaviors Among Patients with Myelodysplastic Syndromes

Kimberly Papay Rogers, Melissa F. Miller, Erica E. Fortune, Tracey Iraca, Stuart L. Goldberg

Blood (2022) 140 (Supplement 1): 8142–8143.

https://doi.org/10.1182/blood-2022-162378

Published: 2022

Journal Articles

Cancer-Related Distress and Risk for Anxiety and Depression Among Lymphoma Survivors

Melissa F. Miller, Erica E. Fortune, Kimberly Papay Rogers, Alexandra K. Zaleta

Blood (2022) 140 (Supplement 1): 10909–10910.

https://doi.org/10.1182/blood-2022-159564

Published: 2022

Journal Articles

Treatment Decision-Making and Decisional Support Experiences Among Acute Myeloid Leukemia Survivors

Elissa C. Kranzler, PhD, Erica E. Fortune, PhD, Melissa F. Miller, PhD MPH, Kelly Clark, MA, Jemeille Ackourey, MPH, Linda Bohannon, RN, BSN, MSM, Heather Badt, MBA, LSS, Thomas W. Leblanc, Jane L. Liesveld, MD, Kristin Scheeler, MS, Alexandra K Zaleta, PhD

Blood (2020) 136 (Supplement 1): 20.

https://doi.org/10.1182/blood-2020-136747

Published: 2020

Journal Articles

Financial Burden Is Associated with Postponing Care and Decreasing Physical and Emotional Quality of Life Among Patients with Multiple Myeloma and Chronic Lymphocytic Leukemia

Erica E. Fortune, PhD, Melissa F. Miller, PhD MPH, Elissa C. Kranzler, PhD, Jemeille Ackourey, MPH, Kelly Clark, MA, Heather Badt, MBA, LSS, Linda Bohannon, RN, BSN, MSM, Craig E. Cole, MD, Thomas W. Leblanc, Alexandra K Zaleta, PhD

Blood (2020) 136 (Supplement 1): 45.

https://doi.org/10.1182/blood-2020-137050

Published: 2020

NARROW

Measuring Social Toxicity in Acute Myeloid Leukemia

Communication That Enables Shared Decision-Making in Myelodysplastic Syndrome Is Suboptimal: Early Results from the Cancer Experience Registry

Financial Toxicity and Cost-Management Behaviors Among Patients with Myelodysplastic Syndromes

Cancer-Related Distress and Risk for Anxiety and Depression Among Lymphoma Survivors

Treatment Decision-Making and Decisional Support Experiences Among Acute Myeloid Leukemia Survivors

Financial Burden Is Associated with Postponing Care and Decreasing Physical and Emotional Quality of Life Among Patients with Multiple Myeloma and Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Measuring Social Toxicity in Acute Myeloid Leukemia

Communication That Enables Shared Decision-Making in Myelodysplastic Syndrome Is Suboptimal: Early Results from the Cancer Experience Registry

Financial Toxicity and Cost-Management Behaviors Among Patients with Myelodysplastic Syndromes

Cancer-Related Distress and Risk for Anxiety and Depression Among Lymphoma Survivors

Treatment Decision-Making and Decisional Support Experiences Among Acute Myeloid Leukemia Survivors

Financial Burden Is Associated with Postponing Care and Decreasing Physical and Emotional Quality of Life Among Patients with Multiple Myeloma and Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only